Two OCRA Heroes are committed to pushing the limits of their physical endurance as a show of solidarity for our community this spring. Ethan Willey from Arizona and Mark Everitt from Connecticut will be taking on swimming, biking and running in order to complete a daunting 70.3 miles during two separate Half Ironman events — … Continued
Spring is officially here, and there’s so much to share — from a roundup on the impact of our risk and prevention campaign, to new ways to get involved and give back. Catch up below. Research Advocacy Patient Support Events Ways to Give Now is the perfect time to think about how charitable giving can … Continued
OCRA’s nationwide campaign promoting risk awareness and consideration of opportunistic salpingectomy, even for those at average risk, has resonated broadly, resulting in widespread media coverage that empowers individuals to take proactive steps in reducing their risk of ovarian cancer. “As the world’s leading ovarian cancer charity we knew we needed to shift the focus to … Continued
We hope you’re feeling the love from the teal community this week, and always. We’re just seven weeks into 2023 and there’s so much to share — new grantees, a new website, and a bold, new direction in the fight against ovarian cancer. Research Advocacy Patient Support Ways to Give Did you know there are three simple ways … Continued
Ovarian cancer is not a single disease, but rather a group of diseases classified by type and subtype. And while they all affect the ovaries, they are quite unique in terms of origin and prognosis. High-grade serous ovarian cancer (HGSOC) is the most common subtype, accounting for the majority of diagnoses, and typically involving a first-line … Continued
Audra Moran, President & CEO of OCRA, joined Katie Couric to explain important new developments around symptoms and early detection of ovarian cancer, and what this means for the future. “A seminal study came out about a year and a half ago that showed, unfortunately, that early detection of ovarian cancer, even in an earlier … Continued
OCRA is pleased to award $7 million in ovarian cancer research funding for 2023, representing the largest annual research investment in our history. With this funding, 20 cancer researchers at 15 medical institutions across the country will pursue projects that break new ground in the fight against this disease. Selected by OCRA’s Scientific Advisory Committee for their potential … Continued
OCRA’s President & CEO, Audra Moran, spoke with CBS New York about the newest ovarian cancer risk and prevention updates, in an important segment timed to Ovarian Cancer Awareness Month.
An article published on February 2nd in The Washington Post highlights a turning point in our fight against ovarian cancer. As covered in the article, “Fallopian tube removal advised for more women to prevent ovarian cancer,” OCRA released a consensus statement, endorsed by the Society of Gynecologic Oncology, encouraging an aggressive prevention strategy: removal of the fallopian … Continued
An article published on February 1st in The New York Times highlights a turning point in our fight against ovarian cancer. As covered in the article, “To Prevent Cancer, More Women Should Consider Removing Fallopian Tubes, Experts Say,” OCRA is launching an important campaign centered around two messages with proven outcomes: knowing one’s risk, and … Continued
Today marks a turning point in our fight against ovarian cancer. As covered in The New York Times, we are launching an important campaign centered around two messages with proven outcomes: knowing one’s risk, and taking preventative action. You know better than anyone the challenges we face in the fight against ovarian cancer. There’s no … Continued
[NEW YORK, Feb. 1, 2023] — In a dramatic shift of focus in the fight against ovarian cancer, Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian cancer organization, today announced they will begin a nationwide push for genetic testing of those at increased risk and consideration of a prophylactic surgery even for those at average risk to potentially … Continued
Get email updates about research news, action alerts, and ways to join the fight.
